Medical Doctor Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Pamela Moore

Internal Medicine Plano, TX Medical Doctor

NPI 1598838435 CMS profile 118001

6300 Stonewood Dr, #200, Plano, TX 75024

Open in the dashboard

General payments

$1,972

144 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$1,467,460 paid to institutions, not to them · program years 2019–2024

Through program year 2023, Pamela Moore of Plano, TX is reported in the CMS Open Payments database as having received $1,972 across 144 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $1,467,460 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 79th percentile of Internal Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $38 1
2021 General $267 11
2020 General $294 19
2019 General $1,374 113

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Pamela Moore
  • Internal Medicine median
  • Middle half of Internal Medicine
  • National median

In program year 2025, general payments to Pamela Moore were reported at $0. Among 52,115 Internal Medicine profiles paid that year, the median was $156 and the middle half received between $47 and $551.

Show as a table
Year Pamela Moore Internal Medicine median Middle half National median
2019 $1,374 $159 $48–$570 $163
2020 $294 $119 $33–$402 $114
2021 $267 $135 $37–$521 $132
2022 $0 $141 $42–$496 $149
2023 $38 $149 $45–$519 $160
2024 $0 $154 $47–$537 $164
2025 $0 $156 $47–$551 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. Novo Nordisk Inc $448 46 payments
  2. AstraZeneca Pharmaceuticals LP $188 13 payments
  3. Amarin Pharma Inc. $179 20 payments
  4. Merck Sharp & Dohme Corporation $169 12 payments
  5. Astellas Pharma US Inc $164 5 payments
  6. AbbVie, Inc. $150 8 payments
  7. GlaxoSmithKline, LLC. $120 7 payments
  8. Kowa Pharmaceuticals America, Inc. $85 5 payments
  9. Allergan Inc. $62 5 payments
  10. Salix Pharmaceuticals, a division of Bausch Health US, LLC $57 3 payments
  11. Other $350 20 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $1,856 141 payments
  2. Education $117 3 payments
Products named General payments · program years 2019–2023
  1. Ozempic $258 30 payments
  2. Vascepa $147 18 payments
  3. STEGLATRO $120 9 payments
  4. JANUVIA $119 9 payments
  5. FARXIGA $115 8 payments
  6. Saxenda $97 6 payments
  7. Livalo $85 5 payments
  8. BELSOMRA $79 6 payments
  9. Bystolic $73 4 payments
  10. ANORO $71 4 payments
  11. Other $1,127 74 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

144 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Internal Medicine in Texas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record